Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y

Key Takeaways Repligen posted Q4 2025 EPS of 49 cents, beating estimates. Revenues rose 18% Y/Y to $198M.Repligen delivered 14% organic growth in Q4 2025, with Proteins and Process Analytics up over 30%.Repligen guides 2026 revenues of $810-$840M and estimates EPS to be in the band of $1.93-$2.01.Repligen Corporation (RGEN) reported fourth-quarter 2025 adjusted earnings per share of 49 cents, which came ahead of the Zacks Consensus Estimate and the year-ago adjusted earnings of 44 cents per share.Total reve ...